CD 001
Alternative Names: CD-001Latest Information Update: 11 Oct 2024
At a glance
- Originator CD (Suzhou) Biopharma
- Class Antineoplastics; Antivirals; Cytokines; Immunoglobulin fragments; Immunotherapies; Recombinant fusion proteins
- Mechanism of Action Interleukin 21 replacements; Programmed cell death 1 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Cancer; HIV infections; Human papillomavirus infections